Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Huge Vitamin C Price Increase May Be a Blessing in Disguise for Cancer Patients, Says Vitamin C Foundation
  • USA - English


News provided by

Inteligent*Vitamin*C Inc

Apr 07, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Linus Pauling
Linus Pauling

Naperville, Illinois (PRWEB) April 07, 2015 -- With the recent price jump in sterilized vitamin C for injection, the Vitamin C Foundation shares that the sharp increase may be better for patients in the long term. Doctors who utilize intravenous vitamin C therapy will be spurred to seek out lower-cost options that may work even better.

The Vitamin C Foundation Approved® sodium ascorbate (Cathcart's) formulation is amazing. Again, I was shocked at how superior it was compared to the other vitamin C powder I was using. Patients noticed it; I noticed it…pretty incredible.

Post this

“Prices have more than quadrupled overnight,” says Vitamin C Foundation founder and CEO Owen Fonorow. Factors that have contributed to the price increase include the cost of ingredients, new regulations and restrictions, cost of sterilization and insurance, loss of economy of scale by manufacturers, and increased demand. These changes make it unlikely that pharmacies will be able to offer vitamin C injections at a lower cost in the future.

Intravenous vitamin C (IV/C) is widely used in the treatment of cancer, but it is often an out-of-pocket expense for patients, meaning that even small price increases have serious ramifications. The Vitamin C Foundation believes that doctors will then be motivated to look for lower-cost options and may return to the ways of the early pioneers of vitamin C therapy, which could be a blessing in disguise.

Vitamin C pioneers, such as Fredrick Klenner, MD, Robert Cathcart III, MD, would mix the vitamin for infusion just prior to the intravenous administration, keeping the vitamin fresh. Their methods may be vastly more potent than today’s commercial vials, where the vitamin C is in solution for long periods on the shelf. The results of the early pioneers using vitamin C intravenously were so profound that two-time Nobel Laureate Linus Pauling began championing the cause of vitamin C.

For strictly legal reasons, most doctors have preferred to purchase sterile solutions from national pharmaceutical companies rather than mixing the vitamin C with stock solution shortly prior to use. According to the world expert, the late Robert Cathcart III, MD, the sterility of the stock solution did not worry him “because sodium ascorbate in solution is very bactericidal.” Therefore, there is nothing better than vitamin C itself to sterilize the mixture. More than 14,000 patients from around the world received their intravenous vitamin C from Dr. Cathcart.

“Safety has never been an issue with intravenous vitamin C, even at dosages as high as 200 grams,” says Fonorow. “The new regulations must have more to do with protecting pharmaceutical interests than the public health.”

By mixing prior to infusion, the resulting vitamin C solution is stronger, whereas the Foundation has estimated that the premixed commercial vials of vitamin C for injection may lose 50% potency on the shelf. Even a compounding pharmacist’s solution will experience a loss in potency.

Another problem is that the commercial firms offer the premixed products in vials for injection marked “ascorbic acid.” This mislabeling can be confusing, especially for doctors new to IV/C therapy, because these labels imply that ascorbic acid can be used intravenously. If the company is responsible, these products labeled ascorbic acid for injection are buffered in accordance with the United States Pharmacopeia, but they are still premixed, allowing the ascorbate to rapidly break down by at least 50% in 4 hours.

Experts such as Dr. Cathcart told the Foundation that they recommend using only sodium ascorbate intravenously. Dr. Cathcart recommended using major brands of sodium ascorbate powder, e.g. Bronson or Wholesale Nutrition sodium ascorbate, but the Foundation recommends using the China-free DSM QUALI-C® sodium ascorbate powder.

“The Vitamin C Foundation Approved® sodium ascorbate (Cathcart's) formulation is amazing. Again, I was shocked at how superior it was compared to the other vitamin C powder I was using. Patients noticed it; I noticed it…pretty incredible.” - Daniel C. K., MD, Boston MA

The DSM QUALI-C® (Cathcart's) sodium ascorbate powder approved by the Foundation is less than $50 for 250 grams, versus the $100 dollars from a compounding pharmacist, and $375 for the equivalent in standard vials.

For more information on the preparation and use of intravenous vitamin C, please view this tutorial video or read this document.

Visit our forum conversation on this topic.

About The Vitamin C Foundation
The Vitamin C Foundation is a nonprofit, charitable corporation devoted to preserving the vital knowledge about ascorbic acid and its role in life and use in medicine. Headquartered in Illinois, the Foundation is dedicated to the memory of Linus C. Pauling. The organization has been assigned the IRS tax-exempt 501(c)(3) designation and its activities are funded by charitable contributions.

Vitamin C Foundation Approved® is a registered trademark of the Vitamin C Foundation.

QUALI-C® is a registered trademark of DSM Nutritional Products.

The Vitamin C Foundation
24W500 Maple Ave, Ste. 107, Naperville, IL 60540
Phone– 800-894-9025
Fax – 630-416-1309
vitamincfoundation(at)gmail(dot)com
Contact: Owen Fonorow
Office: 630-983-6707

Owen Fonorow, Inteligent*Vitamin*C Inc, http://immortalcellsciences.com, +1 6309836707, [email protected]

Modal title

Vitamin C Foundation
Vitamin C Foundation
Cathcart's Sodium Ascorbate (QUALI-C)
Cathcart's Sodium Ascorbate (QUALI-C)
Curing the Incurable: Vitamin C, Infectious Disease and Toxins
Curing the Incurable: Vitamin C, Infectious Disease and Toxins
Vitamin C Foundation Cathcart's Sodium Ascorbate (QUALI-C) Curing the Incurable: Vitamin C, Infectious Disease and Toxins

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.